253 related articles for article (PubMed ID: 34118692)
1. High throughput proteomic and metabolic profiling identified target correction of metabolic abnormalities as a novel therapeutic approach in head and neck paraganglioma.
Wang Z; Chen H; Xue L; He W; Shu W; Wu H; Wang Z
Transl Oncol; 2021 Aug; 14(8):101146. PubMed ID: 34118692
[TBL] [Abstract][Full Text] [Related]
2. Identification of a signaling axis HIF-1α/microRNA-210/ISCU independent of SDH mutation that defines a subgroup of head and neck paragangliomas.
Merlo A; de Quiros SB; Secades P; Zambrano I; Balbín M; Astudillo A; Scola B; Arístegui M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2012 Nov; 97(11):E2194-200. PubMed ID: 22977270
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Malignant Head and Neck Paragangliomas at a Single Institution Across Multiple Decades.
McCrary HC; Babajanian E; Calquin M; Carpenter P; Casazza G; Naumer A; Greenberg S; Kohlmann W; Cannon R; Monroe MM; Hunt JP; Buchmann L
JAMA Otolaryngol Head Neck Surg; 2019 Jul; 145(7):641-646. PubMed ID: 31194233
[TBL] [Abstract][Full Text] [Related]
4. Common genetic mutations in the start codon of the SDH subunit D gene among Chinese families with familial head and neck paragangliomas.
Wang CP; Chen TC; Chang YL; Ko JY; Yang TL; Lo FY; Hu YL; Chen PL; Wu CC; Lou PJ
Oral Oncol; 2012 Feb; 48(2):125-9. PubMed ID: 21945342
[TBL] [Abstract][Full Text] [Related]
5. Somatic Mutation Profiling in Head and Neck Paragangliomas.
Savvateeva M; Kudryavtseva A; Lukyanova E; Kobelyatskaya A; Pavlov V; Fedorova M; Pudova E; Guvatova Z; Kalinin D; Golovyuk A; Bulavkina E; Katunina I; Krasnov G; Snezhkina A
J Clin Endocrinol Metab; 2022 Jun; 107(7):1833-1842. PubMed ID: 35460558
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic variability and risk of malignancy in SDHC-linked paragangliomas: lessons from three unrelated cases with an identical germline mutation (p.Arg133*).
Bickmann JK; Sollfrank S; Schad A; Musholt TJ; Springer E; Miederer M; Bartsch O; Papaspyrou K; Koutsimpelas D; Mann WJ; Weber MM; Lackner KJ; Rossmann H; Fottner C
J Clin Endocrinol Metab; 2014 Mar; 99(3):E489-96. PubMed ID: 24423348
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas.
Bernardo-Castiñeira C; Sáenz-de-Santa-María I; Valdés N; Astudillo A; Balbín M; Pitiot AS; Jiménez-Fonseca P; Scola B; Tena I; Molina-Garrido MJ; Sevilla MA; Beristein E; Forga L; Villabona C; Oriola J; Halperin I; Suarez C; Chiara MD
Head Neck; 2019 Jan; 41(1):79-91. PubMed ID: 30549360
[TBL] [Abstract][Full Text] [Related]
9. Nationwide study of patients with head and neck paragangliomas carrying SDHB germline mutations.
Rijken JA; Niemeijer ND; Leemans CR; Eijkelenkamp K; van der Horst-Schrivers ANA; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; van Dooren MF; Hes FJ; Jansen JC; Corssmit EPM; Hensen EF
BJS Open; 2018 Apr; 2(2):62-69. PubMed ID: 29951630
[TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma.
Bayley JP; van Minderhout I; Weiss MM; Jansen JC; Oomen PH; Menko FH; Pasini B; Ferrando B; Wong N; Alpert LC; Williams R; Blair E; Devilee P; Taschner PE
BMC Med Genet; 2006 Jan; 7():1. PubMed ID: 16405730
[TBL] [Abstract][Full Text] [Related]
11. Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations.
Neumann HP; Pawlu C; Peczkowska M; Bausch B; McWhinney SR; Muresan M; Buchta M; Franke G; Klisch J; Bley TA; Hoegerle S; Boedeker CC; Opocher G; Schipper J; Januszewicz A; Eng C;
JAMA; 2004 Aug; 292(8):943-51. PubMed ID: 15328326
[TBL] [Abstract][Full Text] [Related]
12. Identification of somatic VHL gene mutations in sporadic head and neck paragangliomas in association with activation of the HIF-1α/miR-210 signaling pathway.
Merlo A; de Quirós SB; de Santa-María IS; Pitiot AS; Balbín M; Astudillo A; Scola B; Arístegui M; Quer M; Suarez C; Chiara MD
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1661-6. PubMed ID: 23902947
[TBL] [Abstract][Full Text] [Related]
13. Genetic and epigenetic patterns in patients with the head-and-neck paragangliomas associate with differential clinical characteristics.
Chen H; Zhu W; Li X; Xue L; Wang Z; Wu H
J Cancer Res Clin Oncol; 2017 Jun; 143(6):953-960. PubMed ID: 28255624
[TBL] [Abstract][Full Text] [Related]
14. Identification of a novel SDHB c.563 T > C mutation responsible for Paraganglioma syndrome and genetic analysis of the SDHB gene in China: a case report.
Chen H; Yao W; He Q; Yu X; Bian B
BMC Med Genet; 2020 May; 21(1):116. PubMed ID: 32460727
[TBL] [Abstract][Full Text] [Related]
15. Somatostatin Receptor-Directed PET/CT Can Differentiate Between Different Subtypes of Head and Neck Paragangliomas.
Zhi Y; Gerhard-Hartmann E; Hartrampf PE; Weich A; Higuchi T; Bley TA; Hackenberg S; Hagen R; Rosenwald A; Scherzad A; Remde H; Fassnacht M; Werner RA; Serfling SE
Clin Nucl Med; 2023 Nov; 48(11):923-927. PubMed ID: 37756444
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of SDHB, SDHC, and SDHD germline mutations in clinic patients with head and neck paragangliomas.
Baysal BE; Willett-Brozick JE; Lawrence EC; Drovdlic CM; Savul SA; McLeod DR; Yee HA; Brackmann DE; Slattery WH; Myers EN; Ferrell RE; Rubinstein WS
J Med Genet; 2002 Mar; 39(3):178-83. PubMed ID: 11897817
[TBL] [Abstract][Full Text] [Related]
17. High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations.
Lima J; Feijão T; Ferreira da Silva A; Pereira-Castro I; Fernandez-Ballester G; Máximo V; Herrero A; Serrano L; Sobrinho-Simões M; Garcia-Rostan G
J Clin Endocrinol Metab; 2007 Dec; 92(12):4853-64. PubMed ID: 17848412
[TBL] [Abstract][Full Text] [Related]
18. Germline mutations and genotype-phenotype associations in head and neck paraganglioma patients with negative family history in China.
Zhu WD; Wang ZY; Chai YC; Wang XW; Chen DY; Wu H
Eur J Med Genet; 2015 Sep; 58(9):433-8. PubMed ID: 26096992
[TBL] [Abstract][Full Text] [Related]
19. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
20. The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes.
Udager AM; Magers MJ; Goerke DM; Vinco ML; Siddiqui J; Cao X; Lucas DR; Myers JL; Chinnaiyan AM; McHugh JB; Giordano TJ; Else T; Mehra R
Hum Pathol; 2018 Jan; 71():47-54. PubMed ID: 29079178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
